• 1  Feingold A. Good looking people are not what we think. Psychol Bull 1992;111:3041. Cross Ref link
  • 2  Dalgard F, Gieler U, Holm , Bjertness E, et al. Self‐esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol 2008;59(5):74651. Cross Ref link Pubmed link
  • 3  M, Gupta, A. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139(5):84650. Cross Ref link Pubmed link
  • 4  Schneider G, Heuft G, Hockmann J. Determinants of social anxiety and social avoidance in psoriasis outpatients. J Eur Acad Dermatol Venereol 2013;27(3):3836. Cross Ref link Pubmed link
  • 5  Magin P. Appearance‐related bullying and skin disorders. Clin Dermatol 2013;31(1):6671. Cross Ref link Pubmed link
  • 6  Schofield JKL, Fleming D, Grindlay D, Williams H. Skin conditions are the commonest new reason people present to general practitioners in England and Wales. Br J Dermatol 2011 Nov;165(5):104450. Cross Ref link Pubmed link
  • 7  Royal College of General Practitioners (RCGP) Birmingham Research Unit, UK. Weekly Return Service Annual Report, 2006.
  • 8  Bewley A, Affleck A, Bundy C, et al. Psychodermatology services guidance: the report of the British Association of Dermatologists' Psychodermatology Working Party. Br J Dermatol 2013;168(6):114950. Cross Ref link Pubmed link
  • 9  Horne R, Clatworthy J, Polmear A, et al. Do hypertensive patients' beliefs about their illness and treatment influence medication adherence and quality of life? J Human Hypertension 2001;15 Suppl. 1:S658. Cross Ref link
  • 10  Fortune DG, Richards HL, Main CJ, et al. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998;39(2):196201. Cross Ref link Pubmed link
  • 11  Kent G, Keohane S. Social anxiety and disfigurement: The moderating effects of fear of negative evaluation and past experience. Br J Clin Psychol 2001;40(1):2334. Cross Ref link Pubmed link
  • 12  Richards HL, Fortune DG, Griffiths CE, et al. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001;50(1):1115. Cross Ref link Pubmed link
  • 13  NICE (National Institute for Health and Clinical Excellence). Clinical Guideline 91 (CG91). Depression with a chronic physical health problem (CG91), 2009. www.nice.org.uk (last accessed July 2014).
  • 14  Lazarus R, Folkman S. Transactional theory and research on emotions and coping. Eur J Personality 1987;1(3):14169. Cross Ref link
  • 15  Glaser R, Kiecolt‐Glaser JK. Stress‐induced immune dysfunction: implications for health. Nat Rev Immunol 2005;5(3):24351. Cross Ref link Pubmed link
  • 16  Kiecolt‐Glaser JK, Marucha PT, Malarkey WB, et al. Slowing of wound healing by psychological stress. Lancet 1995;346(8984):11946. Cross Ref link Pubmed link
  • 17  Marucha PT, Kiecolt‐Glaser JK, Favagehi M. Mucosal wound healing is impaired by examination stress. Psychosom Med 1998;60(3):3625. Cross Ref link Pubmed link
  • 18  Brosschot JF, Gerin W, Thayer JF. The perseverative cognition hypothesis: a review of worry, prolonged stress‐related physiological activation, and health. J Psychosom Res 2006;60(2):11324. Cross Ref link Pubmed link
  • 19  Nisipeanu P, Korczyn AD. Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993;43(7):131112. Cross Ref link Pubmed link
  • 20  Potter PT, Zautra AJ. Stressful life events' effects on rheumatoid arthritis disease activity. J Consulting Clin Psychol 1997;65(2):31923. Cross Ref link
  • 21  Fortune DG, Richards HL, Griffiths CE, et al. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002;41(2):15774. Cross Ref link Pubmed link
  • 22  Ongenae K, Van Geel N, De Schepper S, et al. Effect of vitiligo on self‐reported health‐related quality of life. Br J Dermatol 2005;152(6):116572. Cross Ref link Pubmed link
  • 23  Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health‐related quality of life. Int J Dermatol 2002;41(3):1518. Cross Ref link Pubmed link
  • 24  Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139(5):84650. Cross Ref link Pubmed link
  • 25  Fortune DG, Richards HL, Griffiths CEM. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005;23(4):68194. Cross Ref link Pubmed link
  • 26  Young Park J, Hyun Rim J, Beom Choe Y, et al. Facial psoriasis: comparison of patients with and without facial involvement. J Am Acad Dermatol 2004;50(4):5824. Cross Ref link Pubmed link
  • 27  Leary M, Rapp SR, Herbst KC, et al. Interpersonal concerns and psychological difficulties of psoriasis patients: effect of disease severity and fear of negative evaluation. Health Psychology 1998;17(6):5306. Cross Ref link Pubmed link
  • 28  Singhal A, Ross J, Seminog O, et al. Risk of self‐harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage. J Roy Soc Med 2014;107(5):194204. Cross Ref link Pubmed link
  • 29  Kurd SK, Troxel AB, Crits‐Christoph P, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population‐based cohort study. Arch Dermatol 2010;146(8):8915. Pubmed link
  • 30  Richards H, Fortune DG, Weidmann A, et al. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 2004;151(6):122733. Cross Ref link Pubmed link
  • 31  Magin P, Adams J, Heading G, et al. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med 2009;14(2):15061. Cross Ref link Pubmed link
  • 32  Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005;6(6):38392. Cross Ref link Pubmed link
  • 33  Golchai J, Khani SH, Heidarzadeh A, et al. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals. Indian J Dermatol 2010;55(4):3524. Cross Ref link Pubmed link
  • 34  Magin P, Adams J, Heading G, et al. Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Physician 2006;52:9789. Pubmed link
  • 35  Purvis D, Robinson E, Merry S, et al. Acne, anxiety, depression and suicide in teenagers: a cross‐sectional survey of New Zealand secondary school students. J Paediatr Child Health 2006;42(12):7936. Cross Ref link Pubmed link
  • 36  Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. N Engl J Med 2001;344(6):460. Cross Ref link Pubmed link
  • 37  Marron SE, Tomas‐Aragones L, Boira S. Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. Acta Dermato‐Venereol 2013;93(6):7016. Cross Ref link
  • 38  Sundström A, Alfredsson L, Sjölin‐Forsberg G, et al. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 2010;341.
  • 39  Bae BG, Oh SH, Park CO, et al. Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy. Acta Dermato‐Venereol 2012;92(1):5761. Cross Ref link
  • 40  Noh S, Kim M, Park CO, et al. Comparison of the psychological impacts of asymptomatic and symptomatic cutaneous diseases: vitiligo and atopic dermatitis. Ann Dermatol 2013;25(4):45461. Cross Ref link Pubmed link
  • 41  Misery L, Finlay AY, Martin N, et al. Atopic dermatitis: impact on the quality of life of patients and their partners. Dermatology 2007;215(2):1239. Cross Ref link Pubmed link
  • 42  Anderson R, Rajagopalan R. Effects of allergic dermatosis on health‐related quality of life. Curr Allergy Asthma Rep 2001;1(4):30915. Cross Ref link Pubmed link
  • 43  Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol 2001;28(8):41923. Cross Ref link Pubmed link
  • 44  Thompson AR, Clarke SA, Newell RJ, et al. Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo. Br J Dermatol 2010;163(3):4816. Cross Ref link Pubmed link
  • 45  Storm A, Benfeldt E, Andersen SE, et al. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 2008;59(6):97580. Cross Ref link Pubmed link
  • 46  Thorneloe RJ, Bundy C, Griffiths CE, et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol 2013;168(1):2031. Cross Ref link Pubmed link
  • 47  Krejci‐Manwaring J, McCarty MA, Camacho F, et al. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006;54(5, Suppl.):S2356. Cross Ref link Pubmed link
  • 48  NICE (National Institute for Health and Clinical Excellence). Clinical Guideline 57 (CG57), Atopic eczema in children. December 2007. www.nice.org.uk (last accessed July 2014).
  • 49  Santer M, Burgess H, Yardley L, et al. Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence. J Adv Nursing 2013;69(11):2493501.
  • 50  Williams HC. Atopic dermatitis. N Engl J Med 2005;352(22):231424. Cross Ref link Pubmed link
  • 51  Su JC, Kemp AS, Varigos GA, et al. Atopic eczema: its impact on the family and financial cost. Arch Dis Child 1997;76(2):15962. Cross Ref link Pubmed link
  • 52  Lewis‐Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006;60(8):98492. Cross Ref link Pubmed link
  • 53  Lawson V, Lewis‐Jones MS, Finlay AY, et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact questionnaire. Br J Dermatol 1998;138(1):10713. Cross Ref link Pubmed link
  • 54  Dahl RE, Bernhisel‐Broadbent J, Scanlon‐Holdford S, et al. Sleep disturbances in children with atopic dermatitis. Arch Pediatr Adolesc Med 1995;149(8):85660. Cross Ref link Pubmed link
  • 55  Porter JR, Beuf AH, Lerner A, et al. Psychosocial effect of vitiligo: A comparison of vitiligo patients with ‘normal’ control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986;15(2, Part 1):2204. Cross Ref link Pubmed link
  • 56  Porter JR, Beuf AH, Lerner AB, et al. The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990;22(2, Part 1):2212. Cross Ref link Pubmed link
  • 57  Kent G, al‐Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21(5):3303. Cross Ref link Pubmed link
  • 58  Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive‐behavioural therapy. Br J Med Psychol 1999;72(3):38596. Cross Ref link Pubmed link
  • 59  Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001;70(3):11836. Cross Ref link Pubmed link
  • 60  Kimball AB, Gieler U, Linder D, et al. Psoriasis: is the impairment to a patient's life cumulative? J Eur Acad Dermatol Venereol 2010;24(9):9891004. Pubmed link
  • 61  Augustin M, Glaeske G, Radtke MA, et al. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010;162(3):6336. Cross Ref link Pubmed link
  • 62  Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 national Psoriasis Foundation Patient‐Membership survey. Arch Dermatol 2001;137(3):2804. Pubmed link
  • 63  Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol 2013;168(3):47485. Cross Ref link Pubmed link
  • 64  Halvorsen JA, Stern RS, Dalgard F, et al. suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population‐based study. J Invest Dermatol 2011;131(2):36370. Cross Ref link Pubmed link
  • 65  Christophers E, Barker JN, Griffiths CE, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010;24(5):54854. Cross Ref link Pubmed link
  • 66  Zachariae H. Prevalence of joint disease in patients with psoriasis – implications for therapy. Am J Clin Dermatol 2003;4(7):4417. Cross Ref link Pubmed link
  • 67  Griffiths CEM, Barker JNWN. Psoriasis 1 – pathogenesis and clinical features of psoriasis. Lancet 2007;370(9583):26371. Cross Ref link Pubmed link
  • 68  Cohen AD, Dreiher J, Shapiro Y, et al. Psoriasis and diabetes: a population‐based cross‐sectional study. J Eur Acad Dermatol Venereol 2008;22(5):5859. Cross Ref link Pubmed link
  • 69  Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006;296:173541. Cross Ref link
  • 70  Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study. Br J Dermatol 2007;157(1):6873. Cross Ref link Pubmed link
  • 71  Gottlieb AB, Chao C, Dann F. Psoriasis comorbidities. J Dermatol Treat 2008;19:521. Cross Ref link
  • 72  Gisondi P, Targher G, Zoppini G, et al. Non‐alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009;51(4):75864. Cross Ref link Pubmed link
  • 73  Mehta NN, Azfar RS, Shin DB, et al. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010;31(8):10006. Cross Ref link Pubmed link
  • 74  Samarasekera EJ, Neilson JM, Warren RB, et al. Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta‐analysis. J Invest Dermatol 2013;133(10):23406. Cross Ref link Pubmed link
  • 75  Nestle FO, Kaplan DH, Barker J. Mechanisms of disease: psoriasis. N Engl J Med 2009;361(5):496509. Cross Ref link Pubmed link
  • 76  Boehncke W‐H, Boehncke S, Schoen MP. Managing comorbid disease in patients with psoriasis. BMJ 2010;Jan 15:340.
  • 77  Kirby B, Richards HL, Mason DL, et al. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008;158(1):13840. Pubmed link
  • 78  Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006;298(7):3218. Cross Ref link Pubmed link
  • 79  Favato G. High incidence of smoking habit in psoriatic patients. Am J Med 2008;121(4):E11. Cross Ref link
  • 80  Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005;141(12):15804. Cross Ref link Pubmed link
  • 81  Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. J Invest Dermatol 2005;125(1):617. Cross Ref link Pubmed link
  • 82  Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body‐mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country‐years and 9.1 million participants. Lancet 2011;377(9765):55767. Cross Ref link Pubmed link
  • 83  Gerdes S, Zahl VA, Weichenthal M, et al. Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology 2010;220(1):3843. Cross Ref link Pubmed link
  • 84  Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital‐treated patients with psoriasis. Arch Dermatol 1999;135(12):14903. Cross Ref link Pubmed link
  • 85  Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: nurses' health study II. Am J Med 2007;120(11):9539. Cross Ref link Pubmed link
  • 86  Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol 2000;43(1):116. Cross Ref link Pubmed link
  • 87  Wolk K, Mallbris L, Larsson P, et al. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Dermato‐Venereol 2009;89(5):4927. Cross Ref link
  • 88  Nelson PA, Barker Z, Griffiths CE, et al. ‘On the surface’: a qualitative study of GPs' and patients' perspectives on psoriasis. BMC Family Practice 2013;14:158. Cross Ref link Pubmed link
  • 89  Nelson PA, Chew‐Graham CA, Griffiths CE, et al. Recognition of need in health care consultations: a qualitative study of people with psoriasis. Br J Dermatol 2013;168(2):35461. Cross Ref link Pubmed link
  • 90  Richards HL, Fortune DG, Weidmann A, et al. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient. Br J Dermatol 2004;151(6):122733. Cross Ref link Pubmed link
  • 91  NICE (National Institute for Health and Clinical Excellence). Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence, 2009. www.nice.org.uk (last accessed July 2014).
  • 92  Ellis RM, Koch LH, McGuire E, et al. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 2011;28(3):2424. Cross Ref link Pubmed link
  • 93  Ersser SJ, Cowdell FC, Latter SM, et al. Self‐management experiences in adults with mild‐moderate psoriasis: an exploratory study and implications for improved support. Br J Dermatol 2010;163(5):10449. Cross Ref link Pubmed link
  • 94  Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life – results of a 1998 National Psoriasis Foundation Patient‐Membership Survey. Arch Dermatol 2001;137(3):2804. Pubmed link
  • 95  Magin P, Adams J, Heading G, et al. The psychological sequelae of psoriasis: results of a qualitative study. Psychol Health Med 2009;14(2):15061. Cross Ref link Pubmed link
  • 96  McHenry PM, Doherty VR. Psoriasis – an audit of patients' views on the disease and its treatment. Br J Dermatol 1992;127(1):1317. Cross Ref link Pubmed link
  • 97  Richards HL, Fortune DG, Griffiths CEM. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol 2006;20(4):3709. Cross Ref link Pubmed link
  • 98  The Psoriasis Association. The Patient Experience. A survey of members of The Psoriasis Association, 2010: Northampton, UK.
  • 99  See Psoriasis: Look Deeper Collaboration, 2012. See Psoriasis: Look Deeper. Recognising the life impact of psoriasis, 2012: https://psoriasis‐association.org.uk/silo/files/SPLD‐Report‐_FINAL‐1.pdf (last accessed July 2014).
  • 100  Phillips LA, Leventhal H, Leventhal EA. Physicians' communication of the common‐sense self‐regulation model results in greater reported adherence than physicians' use of interpersonal skills. Br J Health Psychol 2012;17(2):24457. Cross Ref link Pubmed link
  • 101  The Psoriasis Association. Unpublished report, 2013. Northampton, UK.
  • 102  Richards HL, Fortune DG, Griffiths CE, et al. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale‐20. J Psychosom Res 2005;58(1):8996. Cross Ref link Pubmed link
  • 103  Identification and Management of Psoriasis Associated Co‐Morbidity programme, 2013. www.impactpsoriasis.org.uk (last accessed July 2014).
  • 104  Bundy C, Pinder B, Bucci S, et al. A novel, web‐based, psychological intervention for people with psoriasis: the Electronic Targeted Intervention for Psoriasis (eTIPs)study. Br J Dermatol 2013; 169(2):32936. Cross Ref link Pubmed link